Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.antiviral.2016.09.003
Title: | Single dose of an adenovirus vectored mouse interferon-α protects mice from lethal EV71 challenge | Authors: | Sun, J Ennis, J Turner, JD Chu, JJH |
Keywords: | DEF201 EV71 Murine model Prophylactic effects Therapeutic effects Adenoviridae Animals Antiviral Agents Disease Models, Animal Dose-Response Relationship, Drug Enterovirus A, Human Enterovirus Infections Genetic Vectors Hand, Foot and Mouth Disease Interferon-alpha Interferon-gamma Mice Mice, Inbred BALB C Survival Analysis Viral Load |
Issue Date: | 1-Oct-2016 | Publisher: | Elsevier BV | Citation: | Sun, J, Ennis, J, Turner, JD, Chu, JJH (2016-10-01). Single dose of an adenovirus vectored mouse interferon-α protects mice from lethal EV71 challenge. Antiviral Research 134 : 207-215. ScholarBank@NUS Repository. https://doi.org/10.1016/j.antiviral.2016.09.003 | Abstract: | © 2016 Elsevier B.V. Enterovirus 71 (EV71) causes hand-foot-and-mouth diseases as well as neurological complications in young children. Interferon (IFN) can inhibit the replication of many viruses with low cytotoxic effects. Previously, an adenovirus vectored mouse interferon-α (DEF201), subtype 5, was generated by Wu et al, 2007. In this study, the antiviral effects of DEF201 against EV71 were evaluated in a murine model. 6–day-old BALB/c mice were administered a single dose of DEF201 before or after infection with lethal dose of EV71. The survival rate, clinical symptoms, tissue viral loads and histology pathogenesis were evaluated. IFN gene expression following a single dose of DEF201 maintained high concentrations of 100–9000 pg/mL for more than 7 days in mice serum. Pre-infection administration of a single dose of 106 PFU of DEF201 offered full protection of the mice against EV71 infection compared with the empty Ad5 vector control. In addition, virus load in DEF201-treated mice muscle tissue was significantly decreased as compared with empty vector control. Histopathology analysis revealed that DEF201 significantly prevented the development of severe tissue damage with reduction of viral antigen in the murine muscle tissue. Post-infection treatment at 6 h offered full protection and partial protection at 12 h, indicating that DEF201 could be used as an anti-EV71 therapeutic agent in early stage of EV71 infection. In addition, our study showed that DEF201 enhanced the neutralization ability of serum in EV71-vaccinated mice, implying that DEF201 could promote the production of specific anti-EV71 antibodies. In conclusion, single dose of DEF201 is highly efficacious as a prophylactic agent against EV71 infection in vivo. | Source Title: | Antiviral Research | URI: | https://scholarbank.nus.edu.sg/handle/10635/173208 | ISSN: | 01663542 18729096 |
DOI: | 10.1016/j.antiviral.2016.09.003 |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
18.pdf | Accepted version | 9.86 MB | Adobe PDF | OPEN | Post-print | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.